Radiotherapy after conservative surgery in ductal carcinoma in situ of the breast: A review

International Journal of Surgical Oncology

Volumn 2012, Issue , 2012, Pages

  Amichetti, Maurizio ^a   Vidali, Cristiana ^b  

^a ATreP   (Italy)

^b Azienda Ospedaliero Universitaria   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866252001     PISSN: 20901402     EISSN: 20901410     Source Type: Journal    
DOI: 10.1155/2012/635404     Document Type: Review

References (55)

1. Leonard G. D., Swain S. M., Ductal carcinoma in situ, complexities and challenges. Journal of the National Cancer Institute 2004 96 12 906 920 2-s2.0-2942672535 (Pubitemid 38868137)
2. Boyages J., Delaney G., Taylor R., Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 1999 85 3 616 628 (Pubitemid 29075283)
3. Joslyn S. A., Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival. Breast Journal 2006 12 1 20 27 2-s2.0-33644889095 10.1111/j.1075-122X.2006.00182.x (Pubitemid 43381446)
4. Smith G. L., Smith B. D., Haffty B. G., Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. International Journal of Radiation Oncology Biology Physics 2006 65 5 1397 1403 2-s2.0-33748567783 10.1016/j.ijrobp.2006.03.009 (Pubitemid 44425216)
5. Solin L. J., Fourquet A., Vicini F. A., Taylor M., Olivotto I. A., Haffty B., Strom E. A., Pierce L. J., Marks L. B., Bartelink H., McNeese M. D., Jhingran A., Wai E., Bijker N., Campana F., Hwang W. T., Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 2005 103 6 1137 1146 2-s2.0-20044376865 10.1002/cncr.20886 (Pubitemid 40328083)
6. Cutuli B., Fay R., Cohen-Solal-Le Nir C., De Lafontan B., Mignotte H., Servent V., Giard S., Auvray H., Charra-Brunaud C., Gonzague-Casabianca L., Quetin P., Ductal carcinoma in situ of the breast: analysis of 882 cases. Presse Medicale 2004 33 2 83 89 2-s2.0-10744232119 (Pubitemid 38165888)
7. Vargas C., Kestin L., Go N., Krauss D., Chen P., Goldstein N., Martinez A., Vicini F. A., Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. International Journal of Radiation Oncology Biology Physics 2005 63 5 1514 1521 2-s2.0-27744433970 10.1016/j.ijrobp.2005.04.045 (Pubitemid 41628051)
8. Schouten van der Velden A. P., van Vugt R., Van Dijck J. A. A. M., Leer J. W. H., Wobbes T., Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands. International Journal of Radiation Oncology Biology Physics 2007 69 3 703 710 2-s2.0-34548668896 10.1016/j.ijrobp.2007.03.062 (Pubitemid 47418402)
9. Silverstein M. J., The Van Nuys/University of Southern California experience by treatment. Ductal Carcinoma in Situ of the Breast 2002 2nd Philadelphia, Pa, USA Lippincot Williams and Wilkins 337 342
10. Silverstein M. J., Lagios M. D., Craig P. H., A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996 77 11 2267 2274 (Pubitemid 26162419)
11. Silverstein M. J., The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. American Journal of Surgery 2003 186 4 337 343 2-s2.0-0142182087 10.1016/S0002-9610(03)00265-4 (Pubitemid 38368606)
12. De Mascarel I., Bonichon F., Macgrogan G., De Lara C. T., Avril A., Picot V., Durand M., Mauriac L., Trojani M., Coindre J. M., Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examinated by serial macroscopic sectioning: Practical considerations. Breast Cancer Research and Treatment 2000 61 2 151 159 2-s2.0-0033937207 10.1023/A:1006437902770 (Pubitemid 30456235)
13. MacAusland S. G., Hepel J. T., Chong F. K., Galper S. L., Gass J. S., Ruthazer R., Wazer D. E., An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ. Cancer 2007 110 12 2648 2653 2-s2.0-37049003817 10.1002/cncr.23089 (Pubitemid 350250333)
14. Amichetti M., Caffo O., Richetti A., Zini G., Rigon A., Antonello M., Arcicasa M., Coghetto F., Valdagni R., Maluta S., Di Marco A., Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy. European Journal of Cancer 1997 33 10 1559 1565 2-s2.0-0031427373 10.1016/S0959-8049(97)00137-8 (Pubitemid 28123475)
15. Amichetti M., Caffo O., Richetti A., Zini G., Rigon A., Antonello M., Roncadin M., Coghetto F., Valdagni R., Fasan S., Maluta S., Di Marco A., Neri S., Vidali C., Panizzoni G., Aristei C., Subclinical ductal carcinoma in situ of the breast: treatment with conservative surgery and radiotherapy. Tumori 1999 85 6 488 493 2-s2.0-0033370190 (Pubitemid 30074597)
16. Fisher B., Land S., Mamounas E., Dignam J., Fisher E. R., Wolmark N., Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Seminars in Oncology 2001 28 4 400 418 2-s2.0-0034883290 (Pubitemid 32762083)
17. Fisher E. R., Dignam J., Tan-Chiu E., Pathologic Findings from the National Surgical Adjuvant Breast Project (NSABP) Eight-Year Update of Protocol B-17. Cancer 1999 86 3 429 438 (Pubitemid 29347405)
18. Wapnir I. L., Dignam J. J., Fisher B., Mamounas E. P., Anderson S. J., Julian T. B., Land S. R., Margolese R. G., Swain S. M., Costantino J. P., Wolmark N., Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. Journal of the National Cancer Institute 2011 103 6 478 488 2-s2.0-79952845819 10.1093/jnci/djr027
19. Bijker N., Meijnen P., Peterse J. L., Bogaerts J., Van Hoorebeeck I., Julien J. P., Gennaro M., Rouanet P., Avril A., Fentiman I. S., Bartelink H., Rutgers E. J. T., Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of european organisation for research and treatment of cancer randomized phase III trial 10853a study by the EORTC breast cancer cooperative group and EORTC radiotherapy group. Journal of Clinical Oncology 2006 24 21 3381 3387 2-s2.0-33746811910 10.1200/JCO.2006.06. 1366 (Pubitemid 46638893)
20. Bijker N., Peterse J. L., Julien J. P., Julien J. P., Fentiman I. S., Duval C., Di Palma S., Simony-Lafontaine J., De Mascarel I., Van de Vijver M. J., Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. Journal of Clinical Oncology 2001 19 8 2263 2271 2-s2.0-0035871577 (Pubitemid 32366979)
21. Holmberg L., Garmo H., Granstrand B., Ringberg A., Arnesson L. G., Sandelin K., Karlsson P., Anderson H., Emdin S., Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. Journal of Clinical Oncology 2008 26 8 1247 1252 2-s2.0-41649119767 10.1200/JCO.2007.12.7969
22. Ringberg A., Nordgren H., Thorstensson S., Idvall I., Garmo H., Granstrand B., Arnesson L. G., Sandelin K., Wallgren A., Anderson H., Emdin S., Holmberg L., Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breastresults from the Swedish randomised trial. European Journal of Cancer 2007 43 2 291 298 2-s2.0-33846309700 10.1016/j.ejca.2006.09.018 (Pubitemid 46123991)
23. Coordinating Committee on Cancer Research Ductal Carcinoma in situ Working Party on behalf of DCIS trialists in the UK UK, Australia, New Zealand, Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003 362 95 102
24. Cuzick J., Sestak I., Pinder S. E., Ellis I. O., Forsyth S., Bundred N. J., Forbes J. F., Bishop H., Fentiman I. S., George W. D., Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. The Lancet Oncology 2011 12 1 21 29 2-s2.0-78650700810 10.1016/S1470-2045(10)70266-7
25. Viani G. A., Stefano E. J., Afonso S. L., De Fendi L. I., Soares F. V., Leon P. G., Guimarães F. S., Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiation Oncology 2007 2 1, article no. 28 2-s2.0-34548319130 10.1186/1748-717X-2-28
26. Goodwin A., Parker S., Ghersi D., Wilcken N., Post-operative radiotherapy for ductal carcinoma in situ of the breasta systematic review of the randomised trials. Breast 2009 18 3 143 149 2-s2.0-67349130739 10.1016/j.breast.2009.04. 003
27. Goodwin A., Parker S., Ghersi D., Wilcken N., Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database of Systematic Reviews 2009 1 CD000563 2-s2.0-62449225094
28. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. Journal of the National Cancer Institute. Monographs 2010 2010 41 162 177 2-s2.0-78650717087
29. Hughes L. L., Wang M., Page D. L., Gray R., Solin L. J., Davidson N. E., Lowen M. A., Ingle J. N., Recht A., Wood W. C., Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology 2009 27 32 5319 5324 2-s2.0-73949085809 10.1200/JCO.2009.21.8560
30. Balleine R. L., Webster L. R., Davis S., Salisbury E. L., Palazzo J. P., Schwartz G. F., Cornfield D. B., Walker R. L., Byth K., Clarke C. L., Meltzer P. S., Molecular grading of ductal carcinoma in situ of the breast. Clinical Cancer Research 2008 14 24 8244 8252 2-s2.0-58149340467 10.1158/1078-0432.CCR- 08-0939
31. Omlin A., Amichetti M., Azria D., Cole B. F., Fourneret P., Poortmans P., Naehrig D., Miller R. C., Krengli M., Gutierrez Miguelez C., Morgan D., Goldberg H., Scandolaro L., Gastelblum P., Ozsahin M., Dohr D., Christie D., Oppitz U., Abacioglu U., Gruber G., Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncology 2006 7 8 652 656 2-s2.0-33746447014 10.1016/S1470-2045(06)70765-3 (Pubitemid 44143777)
32. Yerushalmi R., Sulkes A., Mishaeli M., Neumann A., Dinerman M., Sulkes J., Rizel S., Yarom N., Gutman H., Fenig E., Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary? Neoplasma 2006 53 6 507 510 2-s2.0-33846400859 (Pubitemid 46133512)
33. Julian T. B., Land S. R., Wang Y., Is boost therapy necessary in the treatment of DCIS? Journal of Clinical Oncology 2008 26, abstract 537
34. Monteau A., Sigal-Zafrani B., Kirova Y. M., Fourchotte V., Bollet M. A., Vincent-Salomon A., Asselain B., Salmon R. J., Fourquet A., Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage. International Journal of Radiation Oncology Biology Physics 2009 75 4 1021 1028 2-s2.0-70449721901 10.1016/j.ijrobp.2008.12.014
35. Wai E. S., Lesperance M. L., Alexander C. S., Truong P. T., Culp M., Moccia P., Lindquist J. F., Olivotto I. A., Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ. Cancer 2011 117 1 54 62 2-s2.0-78650698502 10.1002/cncr.25344
36. Wong J. S., Kaelin C. M., Troyan S. L., Gadd M. A., Gelman R., Lester S. C., Schnitt S. J., Sgroi D. C., Silver B. J., Harris J. R., Smith B. L., Prospective study of wide excision alone for ductal carcinoma in situ of the breast. Journal of Clinical Oncology 2006 24 7 1031 1036 2-s2.0-33644972703 10.1200/JCO.2005.02.9975 (Pubitemid 46638798)
37. Meijnen P., Oldenburg H. S. A., Peterse J. L., Bartelink H., Rutgers E. J. T., Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Annals of Surgical Oncology 2008 15 1 235 243 2-s2.0-38049162383 10.1245/s10434-007-9659-2
38. Silverstein M. J., Lagios M. D., Groshen S., Waisman J. R., Lewinsky B. S., Martino S., Gamagami P., Colburn W. J., The influence of margin width on local control of ductal carcinoma in situ of the breast. New England Journal of Medicine 1999 340 19 1455 1461 2-s2.0-0033551370 10.1056/NEJM199905133401902 (Pubitemid 29220544)
39. Dunne C., Burke J. P., Morrow M., Kell M. R., Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. Journal of Clinical Oncology 2009 27 10 1615 1620 2-s2.0-63749086807 10.1200/JCO.2008.17.5182
40. Solin L. J., Fourquet A., Vicini F. A., Taylor M., Olivotto I. A., Haffty B., Strom E. A., Pierce L. J., Marks L. B., Bartelink H., McNeese M. D., Jhingran A., Wai E., Bijker N., Campana F., Hwang W. T., Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 2005 103 6 1137 1146 2-s2.0-20044376865 10.1002/cncr.20886 (Pubitemid 40328083)
41. Solin L. J., Fourquet A., Vicini F. A., Taylor M., Haffty B., Strom E. A., Wai E., Pierce L. J., Marks L. B., Bartelink H., Campana F., McNeese M. D., Jhingran A., Olivotto I. A., Bijker N., Hwang W. T., Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. European Journal of Cancer 2005 41 12 1715 1723 2-s2.0-23644462263 10.1016/j.ejca.2005.03.028 (Pubitemid 41132631)
42. Romestaing P., Lehingue Y., Carrie C., Coquard R., Montbarbon X., Ardiet J. M., Mamelle N., Gérard J. P., Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. Journal of Clinical Oncology 1997 15 3 963 968 2-s2.0-0031059354 (Pubitemid 27106278)
43. Bartelink H., Horiot J. C., Poortmans P. M., Struikmans H., Van Den Bogaert W., Fourquet A., Jager J. J., Hoogenraad W. J., Oei S. B., Warlam-Rodenhuis C. C., Pierart M., Collette L., Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-Year results of the randomized boost versus no boost EORTC 22881-10882 trial. Journal of Clinical Oncology 2007 25 22 3259 3265 2-s2.0-34548243731 10.1200/JCO.2007.11.4991 (Pubitemid 47325610)
44. Wong P., Lambert C., Agnihotram R. V., David M., Duclos M., Freeman C. R., Ductal carcinoma in situ-the influence of the radiotherapy boost on local control. International Journal of Radiation Oncology, Biology, Physics 2012 82 2 e153 e158 2-s2.0-79957956199 10.1016/j.ijrobp.2011.03.045
45. Polgár C., Kahán Z., Orosz Z., Gábor G., Hadijev J., Cserni G., Kulka J., Jani N., Sulyok Z., Lázár G., Boross G., Diczházi C., Szabó É.., László Z., Péntek Z., Major T., Fodor J., The role of radiotherapy in the conservative treatment of ductal carcinoma in situ of the breast. Pathology and Oncology Research 2008 14 2 179 192 2-s2.0-58549088126 10.1007/s12253-008-9044-x
46. Azria D., Auvray H., Barillot I., Radiothérapie des carcinomes canalaires in situ: impact du complément d'irradiation du lit tumoral. Cancer/Radiothérapie 2008 12 6-7 571 576
47. Whelan T. J., Kim D. H., Sussman J., Clinical experience using hypofractionated radiation schedules in breast cancer. Seminars in Radiation Oncology 2008 18 4 257 264 2-s2.0-49749100424 10.1016/j.semradonc.2008.04.008
48. Freedman G. M., Anderson P. R., Goldstein L. J., Ma C. M., Li J., Swaby R. F., Litwin S., Watkins-Bruner D., Sigurdson E. R., Morrow M., Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. International Journal of Radiation Oncology Biology Physics 2007 68 2 347 353 2-s2.0-34247877882 10.1016/j.ijrobp.2006.12.035 (Pubitemid 46694170)
49. Constantine C., Parhar P., Lymberis S., Fenton-Kerimian M., Han S. C., Rosenstein B. S., Formenti S. C., Feasibility of accelerated whole-breast radiation in the treatment of patients with ductal carcinoma in situ of the breast. Clinical Breast Cancer 2008 8 3 269 274 2-s2.0-46949103545 10.3816/CBC.2008.n.031 (Pubitemid 351962149)
50. Livi L., Stefanacci M., Scoccianti S., Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. Clinical Oncology (Royal College of Radiologists) 2007 19 2 120 124 (Pubitemid 46172838)
51. Williamson D., Dinniwell R., Fung S., Pintilie M., Done S. J., Fyles A. W., Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ. Radiotherapy and Oncology 2010 95 3 317 320 2-s2.0-77952586025 10.1016/j.radonc.2010.03.021
52. Silverstein M. J., Ductal Carcinoma in Situ of the Breast 2002 2nd Philadelphia, Pa, USA Lippincot Williams and Wilkins
53. Smith B. D., Arthur D. W., Buchholz T. A., Haffty B. G., Hahn C. A., Hardenbergh P. H., Julian T. B., Marks L. B., Todor D. A., Vicini F. A., Whelan T. J., White J., Wo J. Y., Harris J. R., Accelerated partial breast irradiation Consensus Statement from the American Society for Radiation Oncology (ASTRO). International Journal of Radiation Oncology Biology Physics 2009 74 4 987 1001 2-s2.0-67649519727 10.1016/j.ijrobp.2009.02.031
54. Park S. S., Grills I. S., Chen P. Y., Accelerated partial breast irradiation for pure ductal carcinoma in situ. International Journal of Radiation Oncology, Biology, and Physics 2011 81 2 403 408
55. Jeruss J. S., Kuerer H. M., Beitsch P. D., Vicini F. A., Keisch M., Update on DCIS outcomes from the american society of breast surgeons accelerated partial breast irradiation registry trial. Annals of Surgical Oncology 2011 18 1 65 71 2-s2.0-78651360296 10.1245/s10434-010-1192-z